Onconetix, Inc. (ONCO) stock
ONCONasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.15+0.15 (+5.00%)
Close on Nov 18, 2026Market cap $12.44MP/E –Yield –
Onconetix net income
Net income is the profit left for shareholders after every expense, interest and tax.
Onconetix's net income for the twelve months ending Jun 30, 2026 was -$10.20M. For fiscal 2025 it was -$14.03M. The highest annual figure on record is -$3.42M in fiscal 2021.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$14.03M | – |
| FY2024 | Dec 31, 2024 | -$58.69M | – |
| FY2023 | Dec 31, 2023 | -$37.41M | – |
| FY2022 | Dec 31, 2022 | -$13.42M | – |
| FY2021 | Dec 31, 2021 | -$3.42M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$2.87M | – |
| Q1 FY2026 | Mar 31, 2026 | -$4.21M | – |
| Q4 FY2025 | Dec 31, 2025 | $5.67M | – |
| Q3 FY2025 | Sep 30, 2025 | -$8.78M | – |
| Q2 FY2025 | Jun 30, 2025 | -$2.37M | – |
| Q1 FY2025 | Mar 31, 2025 | -$8.55M | – |
| Q4 FY2024 | Dec 31, 2024 | -$29.44M | – |
| Q3 FY2024 | Sep 30, 2024 | -$3.83M | – |
| Q2 FY2024 | Jun 30, 2024 | -$14.31M | – |
| Q1 FY2024 | Mar 31, 2024 | -$11.12M | – |
| Q4 FY2023 | Dec 31, 2023 | -$22.35M | – |
| Q3 FY2023 | Sep 30, 2023 | -$5.35M | – |
| Q4 FY2022 | Dec 31, 2022 | -$3.22M | – |
| Q3 FY2022 | Sep 30, 2022 | -$3.87M | – |
| Q2 FY2022 | Jun 30, 2022 | -$4.26M | – |
| Q1 FY2022 | Mar 31, 2022 | -$2.07M | – |
| Q4 FY2021 | Dec 31, 2021 | -$1.20M | – |
| Q3 FY2021 | Sep 30, 2021 | -$1.10M | – |
| Q2 FY2021 | Jun 30, 2021 | -$792.27K | – |
| Q1 FY2021 | Mar 31, 2021 | -$325.78K | – |
See a number that looks wrong?